Form D Explorer

Inspect source fieldsReport a record issue

Form D — Aegle Therapeutics Corp

0001231919-26-000232 · filed Mar 3, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$700,000
Reported amount sold
$455,695
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Aegle Therapeutics Corp
CIK
1797825
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
400 TRADECENTER
WOBURN, Massachusetts 01801
Phone
781-918-8449

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗